Management of Hypertension: From Landmark Trials to Modern Practice
Hypertension remains a global "silent killer," yet the way we treat it is undergoing a radical shift. Moving beyond simple clinic readings, modern management now blends the hard evidence from with personalized, tech-driven care. 1. The Shift to Intensive Targets
Current practice has moved away from "monotherapy" (using one drug and slowly adding others). 2024 Elevated Blood Pressure and Hypertension Management of Hypertension: Current Practice an...
For many, clinicians now aim for systolic levels as low as 120 mmHg if tolerated, especially for those at high cardiovascular risk. 2. Mandatory Combination Therapy
The 2025 ACC/AHA guidelines and 2024 ESC guidelines now emphasize a target of for most adults. Management of Hypertension: From Landmark Trials to Modern
For years, a target of 140/90 mmHg was the standard. However, data from trials like and HOPE have pushed clinicians toward more intensive goals.
The phrase refers to a comprehensive medical text edited by Vasilios Papademetriou, Emmanuel A. Andreadis, and Charalampia Geladari. The Shift to Intensive Targets Current practice has
Below is a blog post summarizing the current practice and future landscape of hypertension management, incorporating the core themes of that text and the latest 2024–2025 guidelines.